Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+88.2%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+88.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
6.7x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 167.73% |
| 2024 | -177.05% |
| 2023 | -20.01% |
| 2022 | 25.17% |
| 2021 | -10.09% |
| 2020 | -45.17% |
| 2019 | -48.72% |
| 2018 | -17.42% |
| 2017 | 26.29% |
| 2016 | -31.06% |